Trial Profile
An Open Label Positron Emission Tomography (PET) Study to Investigate Brain Penetration by [11C]GW842166 in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GW 842166X (Primary)
- Indications Inflammatory pain
- Focus Pharmacokinetics
- Sponsors GSK
- 29 May 2009 New trial record